Cloning, Characterization, And production of a novel lysozyme by different expression hosts

Journal of Microbiology and Biotechnology

Volumn 24, Issue 10, 2014, Pages 1405-1412

  Zhang, Haifeng ^a   Fu, Gang ^a,b   Zhang, Dawei ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b National Engineering Laboratory for Industrial Enzymes   (China)

Author keywords

Antimicrobial; Bacillus licheniformis; Bacillus subtilis; Lysozyme; Protein expression system

Indexed keywords

LYSOZYME; PEPSIN A; TRYPSIN; ANTIINFECTIVE AGENT; RECOMBINANT PROTEIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS LICHENIFORMIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; FOOD; HETEROLOGOUS EXPRESSION; MOLECULAR CLONING; NONHUMAN; PH; PROTEIN EXPRESSION; TEMPERATURE; BACILLUS; CHEMISTRY; DRUG EFFECTS; ENZYME STABILITY; ENZYMOLOGY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY;

BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS;

ANTI-INFECTIVE AGENTS; BACILLUS; CLONING, MOLECULAR; ENZYME STABILITY; ESCHERICHIA COLI; GENE EXPRESSION; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MURAMIDASE; RECOMBINANT PROTEINS; SOIL MICROBIOLOGY; TEMPERATURE;

EID: 84923462537     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1404.04039     Document Type: Article

References (36)

1. Abergel C, Monchois V, Byrne D, Chenivesse S, Lembo F, Lazzaroni JC, Claverie JM. 2007. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in gram-negative bacteria. Proc. Natl. Acad. Sci. USA 104: 6394-6399.
2. Callewaert L, Michiels CW. 2010. Lysozymes in the animal kingdom. J. Biosci. 35: 127-160.
3. Casaite V, Bruzyte S, Bukauskas V, Setkus A, Morozova-Roche LA, Meskys R. 2009. Expression and purification of active recombinant equine lysozyme in Escherichia coli. Protein Eng. Des. Sel. 22: 649-654.
4. Chiang CJ, Chen PT, Chao YP. 2010. Secreted production of Renilla luciferase in Bacillus subtilis. Biotechnol. Prog. 26: 58 9-594.
5. Dong H, Zhang D. 2014. Current development in genetic engineering strategies of Bacillus species. Microb. Cell Fact. 13: 63.
6. During K. 1993. A tightly regulated system for overproduction of bacteriophage T4 lysozyme in Escherichia coli. Protein Expr. Purif. 4: 412-416.
7. Ellison RT III, Giehl TJ. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88: 1080-1091.
8. Ercan D, Demirci A. 2013. Production of human lysozyme in biofilm reactor and optimization of growth parameters of Kluyveromyces lactis K7. Appl. Microbiol. Biotechnol. 97: 6211-6221.
9. Fischer B, Perry B, Phillips G, Sumner I, Goodenough P. 1993. Physiological consequence of expression of soluble and active hen egg white lysozyme in Escherichia coli. Appl. Microbiol. Biotechnol. 39: 537-540.
10. Fischer B, Perry B, Sumner I, Goodenough P. 1992. A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. Protein Eng. 5: 593-596.
11. Goto T, Abe Y, Kakuta Y, Takeshita K, Imoto T, Ueda T. 2007. Crystal structure of Tapes japonica lysozyme with substrate analogue: structural basis of the catalytic mechanism and manifestation of its chitinase activity accompanied by quaternary structural change. J. Biol. Chem. 282: 27459-27467.
12. Hayano T, Hirose M, Kikuchi M. 1995. Protein disulfide isomerase mutant lacking its isomerase activity accelerates protein folding in the cell. FEBS Lett. 377: 505-511.
13. Hultmark D, Steiner H, Rasmuson T, Boman HG. 1980. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 106: 7-16.
14. Jolles P, Jolles J. 1984. What’s new in lysozyme research? Always a model system, today as yesterday. Mol. Cell. Biochem. 63: 165-189.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
16. Lamppa JW, Tanyos SA, Griswold KE. 2013. Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme. J. Biotechnol. 164: 1-8.
17. Lewinstein I, Matalon S, Slutzkey S, Weiss EI. 2005. Antibacterial properties of aged dental cements evaluated by direct-contact and agar diffusion tests. J. Prosthet. Dent. 93: 364-371.
18. Maullu C, Lampis G, Desogus A, Ingianni A, Rossolini GM, Pompei R. 1999. High-level production of heterologous protein by engineered yeasts grown in cottage cheese whey. Appl. Environ. Microbiol. 65: 2745-2747.
19. Monchois V, Abergel C, Sturgis J, Jeudy S, Claverie JM. 2001. Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J. Biol. Chem. 276: 18437-18441.
20. Petsch D, Anspach FB. 2000. Endotoxin removal from protein solutions. J. Biotechnol. 76: 97-119.
21. Qasba PK, Kumar S. 1997. Molecular divergence of lysozymes and alpha-lactalbumin. Crit. Rev. Biochem. Mol. Biol. 32: 255-306.
22. Sawano H, Koumoto Y, Ohta K, Sasaki Y, Segawa S, Tachibana H. 1992. Efficient in vitro folding of the three-disulfide derivatives of hen lysozyme in the presence of glycerol. FEBS Lett. 303: 11-14.
23. Schlorb C, Ackermann K, Richter C, Wirmer J, Schwalbe H. 2005. Heterologous expression of hen egg white lysozyme and resonance assignment of tryptophan side chains in its non-native states. J. Biomol. NMR 33: 95-104.
24. Schwartzman B, Caputo AA, Schein B. 1980. Antimicrobial action of dental cements. J. Prosthet. Dent. 43: 309-312.
25. Simonen M, Palva I. 1993. Protein secretion in Bacillus species. Microbiol. Rev. 57: 109-137.
26. van Dijl JM, Hecker M. 2013. Bacillus subtilis: from soil bacterium to super-secreting cell factory. Microb. Cell Fact. 12: 3.
27. Wang F, Qu H, Zhang D, Tian P, Tan T. 2007. Production of 1,3-propanediol from glycerol by recombinant E. coli using incompatible plasmids system. Mol. Biotechnol. 37: 112-119.
28. Wei JT, Tang CD, Wu MC, Liu GL, Shi HL, Li JF. 2012. Cloning and functional expression of a human lysozyme gene (hly) from human leukocytes in Pichia pastoris. Mol. Med. Rep. 6: 173-178.
29. Westers L, Westers H, Quax WJ. 2004. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta 1694: 299-310.
30. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, et al. 2007. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 104: 8101-8106.
31. Wilken LR, Nikolov ZL. 2011. Process evaluations and economic analyses of recombinant human lysozyme and hen egg-white lysozyme purifications. Biotechnol. Prog. 27: 733-743.
32. Yeh CM, Yeh CK, Hsu XY, Luo QM, Lin MY. 2008. Extracellular expression of a functional recombinant Ganoderma lucidium immunomodulatory protein by Bacillus subtilis and Lactococcus lactis. Appl. Environ. Microbiol. 74: 1039-1049.
33. Zhang D, Shan SO. 2012. Translation elongation regulates substrate selection by the signal recognition particle. J. Biol. Chem. 287: 7652-7660.
34. Zhang D, Shrestha B, Li Z, Tan T. 2007. Ubiquinone-10 production using Agrobacterium tumefaciens dps gene in Escherichia coli by coexpression system. Mol. Biotechnol. 35: 1-14.
35. Zhang D, Sweredoski MJ, Graham RL, Hess S, Shan SO. 2012. Novel proteomic tools reveal essential roles of SRP and importance of proper membrane protein biogenesis. Mol. Cell. Proteomics 11: M111011585.
36. Zipperle GF Jr, Ezzell JW Jr, Doyle RJ. 1984. Glucosamine substitution and muramidase susceptibility in Bacillus anthracis. Can. J. Microbiol. 30: 553-559.